Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Milagros Matta
OpenAlex ID:
A5073787234
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
2025
·
Javed Butler
, Ciaran J McMullan
, et al.
·
The Lancet
·
93
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
2020
·
Carolyn S. P. Lam
, Anna Giczewska
, et al.
·
JAMA Cardiology
·
85
PDF
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
2025
·
Faiez Zannad
, Christopher M O'Connor
, et al.
·
The Lancet
·
51
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
2026
·
Francesco Fioretti
, Faiez Zannad
, et al.
·
European Journal of Heart Failure
·
1
Show more works
View as search
Works count:
5
Citation count:
281
H-index:
4
I10-index:
4
Year
Topic
Type
